DYADIC INTERNATIONAL INC Costs and Expenses
DYADIC INTERNATIONAL INC (DYAI) reported Costs and Expenses of $3.02 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-12
- DYADIC INTERNATIONAL INC costs and expenses for the quarter ending 2026-06-30 was $3.02M, a 11.86% increase year-over-year.
- DYADIC INTERNATIONAL INC costs and expenses for the quarter ending 2026-03-31 was $3.01M, a 25.78% increase year-over-year.
- DYADIC INTERNATIONAL INC costs and expenses for the quarter ending 2025-12-31 was $2.10M, a 10.48% decline year-over-year.
- DYADIC INTERNATIONAL INC costs and expenses for the quarter ending 2025-09-30 was $3.09M, a 43.05% increase year-over-year.
- DYADIC INTERNATIONAL INC costs and expenses for fiscal 2025 was $10.28M, a 9.44% increase from fiscal 2024.
- DYADIC INTERNATIONAL INC costs and expenses for fiscal 2024 was $9.40M, a 15.57% decline from fiscal 2023.
- DYADIC INTERNATIONAL INC costs and expenses for fiscal 2023 was $11.13M, a 15.02% decline from fiscal 2022.
- DYADIC INTERNATIONAL INC costs and expenses for fiscal 2022 was $13.10M, a 23.56% decline from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.02M 10-Q · filed 2026-08-12 | $6.03M 10-Q · filed 2026-08-12 | $8.13M derived: sum of 3 quarters · filed 2026-08-12 | $11.22M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $3.01M 10-Q · filed 2026-05-13 | $5.12M derived: sum of 2 quarters · filed 2026-05-13 | $8.21M derived: sum of 3 quarters · filed 2026-05-13 | $10.90M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $5.19M derived: sum of 2 quarters · filed 2026-03-25 | $7.89M derived: sum of 3 quarters · filed 2026-08-12 | $10.28M 10-K · filed 2026-03-25 | |
| 2025-09-30 | $3.09M 10-Q · filed 2025-11-12 | $5.79M derived: sum of 2 quarters · filed 2026-08-12 | $8.18M 10-Q · filed 2025-11-12 | $10.53M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $2.70M 10-Q · filed 2026-08-12 | $5.09M 10-Q · filed 2026-08-12 | $7.44M derived: sum of 3 quarters · filed 2026-08-12 | $9.60M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $2.40M 10-Q · filed 2026-05-13 | $4.74M derived: sum of 2 quarters · filed 2026-05-13 | $6.90M derived: sum of 3 quarters · filed 2026-05-13 | $9.33M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $4.51M derived: sum of 2 quarters · filed 2026-03-25 | $6.94M derived: sum of 3 quarters · filed 2026-03-25 | $9.40M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $2.16M 10-Q · filed 2025-11-12 | $4.59M derived: sum of 2 quarters · filed 2025-11-12 | $7.05M 10-Q · filed 2025-11-12 | $9.90M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $2.43M 10-Q · filed 2025-08-13 | $4.89M 10-Q · filed 2025-08-13 | $7.74M derived: sum of 3 quarters · filed 2025-08-13 | $9.86M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $2.46M 10-Q · filed 2025-05-14 | $5.32M derived: sum of 2 quarters · filed 2025-05-14 | $7.43M derived: sum of 3 quarters · filed 2025-05-14 | $10.56M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $4.97M derived: sum of 2 quarters · filed 2025-03-26 | $8.10M derived: sum of 3 quarters · filed 2025-03-26 | $11.13M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $2.12M 10-Q · filed 2024-11-12 | $5.24M derived: sum of 2 quarters · filed 2024-11-12 | $8.27M 10-Q · filed 2024-11-12 | $11.26M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $3.13M 10-Q · filed 2024-08-13 | $6.16M 10-Q · filed 2024-08-13 | $9.14M derived: sum of 3 quarters · filed 2024-08-13 | $11.88M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $3.03M 10-Q · filed 2024-05-14 | $6.01M derived: sum of 2 quarters · filed 2024-05-14 | $8.75M derived: sum of 3 quarters · filed 2024-05-14 | $12.73M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $5.73M derived: sum of 2 quarters · filed 2024-03-28 | $9.70M derived: sum of 3 quarters · filed 2024-03-28 | $13.10M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $2.74M 10-Q · filed 2023-11-08 | $6.72M derived: sum of 2 quarters · filed 2023-11-08 | $10.11M 10-Q · filed 2023-11-08 | $14.64M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $3.98M 10-Q · filed 2023-08-09 | $7.37M 10-Q · filed 2023-08-09 | $11.90M derived: sum of 3 quarters · filed 2023-08-09 | $15.92M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $3.39M 10-Q · filed 2023-05-10 | $3.39B 10-Q · filed 2022-05-12 | $7.92M derived: sum of 2 quarters · filed 2023-05-10 | $11.94M derived: sum of 3 quarters · filed 2023-05-10 | $16.74M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $8.55M derived: sum of 2 quarters · filed 2023-03-29 | $13.35M derived: sum of 3 quarters · filed 2023-03-29 | $17.13M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $4.02M 10-Q · filed 2022-11-10 | $8.82M derived: sum of 2 quarters · filed 2022-11-10 | $12.60M 10-Q · filed 2022-11-10 | $3.79B derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $4.80M 10-Q · filed 2022-08-10 | $8.59M 10-Q · filed 2022-08-10 | $3.79B derived: sum of 3 quarters · filed 2022-08-10 | $3.79B derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $3.78B 10-Q · filed 2022-05-12 | $3.78M 10-Q · filed 2021-05-13 | $3.78B derived: sum of 2 quarters · filed 2022-05-12 | $3.79B derived: sum of 3 quarters · filed 2022-05-12 | $3.79B derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $5.61M derived: sum of 2 quarters · filed 2022-03-29 | $8.93M derived: sum of 3 quarters · filed 2022-03-29 | $11.63M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $2.99M 10-Q · filed 2021-11-10 | $6.31M derived: sum of 2 quarters · filed 2021-11-10 | $9.01M 10-Q · filed 2021-11-10 | $11.38M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $3.32M 10-Q · filed 2021-08-12 | $6.02M 10-Q · filed 2021-08-12 | $8.39M derived: sum of 3 quarters · filed 2021-08-12 | $10.79M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $2.70M 10-Q · filed 2021-05-13 | $5.07M derived: sum of 2 quarters · filed 2021-05-13 | $7.47M derived: sum of 3 quarters · filed 2021-05-13 | $10.82M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $4.77M derived: sum of 2 quarters · filed 2021-03-30 | $8.12M derived: sum of 3 quarters · filed 2021-03-30 | $10.96M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $2.40M 10-Q · filed 2020-11-12 | $5.75M derived: sum of 2 quarters · filed 2020-11-12 | $8.59M 10-Q · filed 2020-11-12 | $11.05M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $3.35M 10-Q · filed 2020-08-13 | $6.20M 10-Q · filed 2020-08-13 | $8.65M derived: sum of 3 quarters · filed 2020-08-13 | $10.69M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $2.84M 10-Q · filed 2020-05-14 | $5.30M derived: sum of 2 quarters · filed 2020-05-14 | $7.34M derived: sum of 3 quarters · filed 2020-05-14 | $9.32M derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $4.50M derived: sum of 2 quarters · filed 2020-03-30 | $6.47M derived: sum of 3 quarters · filed 2020-03-30 | $8.89M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $2.04M 10-Q · filed 2019-11-13 | $4.02M derived: sum of 2 quarters · filed 2019-11-13 | $6.44M 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $1.98M 10-Q · filed 2019-08-13 | $4.39M 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $2.41M 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | $7.89M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |